Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > .075 is still my call for v.VXL by mid week or so of next :(

<< Previous

Bullboard Posts

Next >>

Comment by Nighttradeon Aug 06, 2020 2:10pm

48 Views

Post# 31374367

RE:RE:.075 is still my call for v.VXL by mid week or so of next :(

Based on the fact that Vaxil has screwed share holds for 2 to 3 months. Until proven otherwise this has been a classic pump and dump. Info, info, info, trap share holders, go silent, then the bottom drops out.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season